Target intelligence / Profile preview

Pleiotrophin (PTN)

Target
PTN
Molecular classification
Cytokine, Growth factor, Extracellular matrix-associated protein, Heparin-binding protein, Other
01

Overview

Pleiotrophin (PTN) is a secreted heparin-binding growth factor and cytokine with a molecular weight of 18 kDa, encoded by the human *PTN* gene[2]. It is structurally related to midkine and functions in cellular proliferation, differentiation, and survival, especially during embryonic development of the nervous system and in processes such as neurite outgrowth, synaptic plasticity, and angiogenesis[2][3]. PTN is expressed in both neural and non-neural tissues and re-expressed during pathology, notably in tumor cells where it promotes tumor growth and angiogenesis[2]. PTN signals through multiple cell surface receptors including RPTPζ, ALK, N-syndecan, LRP, and integrin ανβ3, triggering downstream signaling pathways associated with the extracellular matrix[3]. It plays important roles in neurodevelopment, neuroregeneration after injury, and modulation of memory-related pathways in the hippocampus, but its overexpression can support tumor progression and pathological angiogenesis[2][3].

Other names
Heparin-binding brain mitogenHeparin-binding growth factor 8Heparin-binding growth-associated moleculeHeparin-binding neurite outgrowth-promoting factorNeurite growth-promoting factor 1Heparin affinity regulatory peptideHARPHB-GAMHBNFHBGF-8HBGF8HBNF-1NEGF1OSF-1Osteoblast-specific factor 1
02

Mechanism of action

Inhibition or activation of cell proliferation and survival pathways through interaction with receptor protein tyrosine phosphatase ζ (RPTPζ), Anaplastic lymphoma kinase (ALK), N-syndecan, integrin ανβ3, and low-density lipoprotein receptor-related protein (LRP) pathways; influences ERK, PI3K/AKT, STAT5, and other downstream signaling cascades[3].

03

Biological functions

Cell proliferationCell differentiationNeuronal developmentNeuromodulationNeurite outgrowthSynaptic plasticityAxonal regenerationAngiogenesisCell migration
04

Disease associations

CancerNeurodegenerative diseaseInflammationInjury responseOther
05

Safety considerations

Potential oncogenicity due to its role in tumor cell proliferation and angiogenesisoff-target effects on neural plasticity and neuroprotectionmay complicate targeted therapy due to its pleiotropic and context-dependent functions[2][3]
06

Biomarkers

Elevated PTN expression as a marker in some cancers and neurodegenerative conditions[2]possible use as a biomarker for tumor progression, angiogenesis, and injury response

Beyond the preview

Go deeper on Pleiotrophin (PTN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pleiotrophin (PTN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call